晚年抑郁症的数据驱动子类型 - - 集群随机化RCT的二次分析
Judith van Diepen1,2, Gert-Jan Hendriks2,3,4, Marij Zuidersma5
1Department of Primary and Community Care, Radboud University Medical Center, Research institute of Health Sciences, Nijmegen, Netherlands.
Aging & mental health
|February 23, 2025
概括
研究人员根据症状和认知功能确定了五个不同的晚年抑郁症子组. 行为激活 (BA) 在各个子组中显示出一致的有效性,与通常治疗 (TAU) 不同,这种治疗在严重抑郁症中效果较差.
科学领域:
- 老年精神病学是一门精神病学专业.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 认知表现的变化影响了老年抑郁症患者的治疗结果.
- 晚年抑郁症呈现出多样化的症状形状和认知缺陷.
- 了解抑郁症亚型对于个性化治疗策略至关重要.
研究的目的:
- 用数据驱动方法识别晚年抑郁症患者的不同亚组.
- 在两个治疗条件下,探索不同小组的抑郁症状的过程:行为激活 (BA) 和通常的治疗 (TAU).
- 调查BA与TAU在已识别的抑郁症亚型中的差异性有效性.
主要方法:
- 隐性类分析 (LCA) 对161名患有抑郁症 (PHQ ≥10) 的老年人 (≥65岁) 的抑郁症状和认知测试表现进行了分析.
- 参与者是初级保健中集群随机对照试验的一部分.
- 抑郁症状的纵向过程在BA和TAU下对每个已识别的子组进行了可视化.
主要成果:
- 确定了五个不同的晚年抑郁症子组,其特点是症状严重程度不同,以及认知缺陷的存在/不存在.
- 小组包括:轻度抑郁症没有认知缺陷;中度抑郁症失眠和认知缺陷;严重抑郁症认知缺陷;中度严重抑郁症高睡眠和认知缺陷;中度严重抑郁症认知-情感症状但没有认知缺陷.
- 与TAU相比,在BA期间患有严重抑郁症的子组中,抑郁症状的改善更为显著,无论认知状态如何.
结论:
- 确定了五个不同的晚年抑郁症子组,突出了症状表现和认知参与的异质性.
- 行为激活 (BA) 在所有已识别的子组中表现出一致的有效性.
- 常规治疗 (TAU) 在经历更严重抑郁症状的小组中似乎效果较差,这表明需要量身定制的干预措施.
相关概念视频
01:27Depressive Disorders: MDD and Dysthymia
30
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
30
02:20Longitudinal Research
11.8K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.8K
01:23Antidepressant Drugs: MAOIs and Other Agents
178
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
178
01:27Depressive Disorders: Etiology
29
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
29
01:26Longitudinal Studies
119
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
119